Page last updated: 2024-10-28

guanfacine and Bright Disease

guanfacine has been researched along with Bright Disease in 1 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research Excerpts

ExcerptRelevanceReference
"Effects of guanfacine, a centrally acting antihypertensive, on blood pressure, heart rate, plasma renin activity, serum aldosterone, plasma norepinephrine, and renal function were evaluated in 16 patients with hypertension with biopsy-proved chronic glomerulonephritis."7.67Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis. ( Gomi, T; Ikeda, T; Nakayama, D; Sakurai, J; Yuhara, M, 1988)
"Effects of guanfacine, a centrally acting antihypertensive, on blood pressure, heart rate, plasma renin activity, serum aldosterone, plasma norepinephrine, and renal function were evaluated in 16 patients with hypertension with biopsy-proved chronic glomerulonephritis."3.67Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis. ( Gomi, T; Ikeda, T; Nakayama, D; Sakurai, J; Yuhara, M, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, T1
Gomi, T1
Yuhara, M1
Sakurai, J1
Nakayama, D1

Other Studies

1 other study available for guanfacine and Bright Disease

ArticleYear
Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
    Clinical pharmacology and therapeutics, 1988, Volume: 43, Issue:3

    Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Catecholamines; Chronic Disease; Drug A

1988